However, there are some reviews in which H-FABP seemed to have some prognostic value for patients with acute coronary syndrome, but supplementary studies are needed to evaluate whether there is a correlation between this and adverse outcomes [125,126]. Here, FABP3 is linked to acute coronary syndrome.